Tiziana Life Sciences Share Discussion Threads

[the imperialist] 06/9/2023 13:15

Share price looks ready to blow. Maybe that's the catalyst we're all waiting for.

[jpuff] 06/9/2023 13:04

On September 6, 2023, Tiziana Life Sciences LTD (the "Company") issued a press release, announcing the acceptance of a publication, "Nasal Administration of anti-CD3 monoclonal antibody (mAb) ameliorates disease in a mouse model of Alzheimer's disease", in the preeminent journal, Proceedings of the National Academy of Sciences (PNAS), that supports foralumab's mechanism as a potential treatment for Alzheimer's disease (AD), a difficult-to-treat neuroinflammatory disease. This is the second publication pertaining to intranasal administration of anti-CD3 monoclonal antibody this year to be published in PNAS.

[ih_451482] 15/8/2023 20:21

Recalling the fireworks of 2020. Light the touch paper, Rodney!

[jpuff] 15/8/2023 15:57

https://www.allpennystocks.com/specialreportsus/3350/biotech-shares-experience-massive-premarket-buying-pressure?utm_source=advfn

[jpuff] 15/8/2023 15:38

A small cap in the biotech space is gaining some serious steam during Tuesday's premarket hours after the company announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for intranasal foralumab to be studied in Alzheimer's disease.

[jpuff] 15/8/2023 15:37

This major announcement had traders eager to get their hands on shares of Tiziana Life Sciences Ltd. (Nasdaq:TLSA) ahead of any potential major moves that come from the news. At the time of writing, shares of this stock are bid up at $0.915/share, which indicates an implied open +51.92% higher than yesterday's close.Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn's Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.

[marcus80] 05/6/2023 19:47

joking!! same story as last year. dilution is the solution here! trade it!! don't hold it!!

[jpuff] 05/6/2023 19:20

Just buy and hold is my tactic but noAdvice Intended as we all must make our own investment decisions

[dan161] 05/6/2023 19:18

crazy share this. up 20% now down 10%

[jpuff] 05/6/2023 16:09

June 5, 2023 10:00 AM EDTTiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis

[jpuff] 05/6/2023 14:48

We're gaining traction now folks. GLA and just filter the idiots on this bb ;)

[jpuff] 17/5/2023 12:21

Tiziana Life Sciences Announces Chief Medical Officer Invited to Give Presentation on Intranasal Foralumab on May 17May 17, 2023 at 7:00 AM EDTNEW YORK, May 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that its Chief Medical Officer is presenting at the Hanson Wade Novel Nasal Formulation and Delivery Summit on May 17 in San Diego."I was truly honored when Hanson Wade contacted me requesting that I speak at its Novel Nasal Formulation and Delivery Summit1," stated Matthew W. Davis, M.D., RPh, Chief Medical Officer of Tiziana. "I will be joined at the summit by several distinguished speakers from the industry and the FDA.2 The continued interest we receive on our intranasal foralumab program from pharma, investors and the media demonstrates that our novel approach to deliver the only fully human anti-CD3 monoclonal antibody intranasally has captured the attention of the medical community."

[jpuff] 08/5/2023 20:59

https://youtu.be/h8lhg1Y22Ko

[jpuff] 05/5/2023 19:48

Don't worry about me mate as I'm very comfortably retired without the on going worries you seem to have about TILS. Is it OCD as you can get help for that!

[lean5gb] 05/5/2023 19:13

Re read my posts and you'll find out i have moved on after trading the highs and lows, and re couping any losses I made.I honestly feel for you...Oh, and I very much doubt that you are a 'happy long termer'.. :0))))))

[jpuff] 05/5/2023 13:29

What interest do you have in the company then Lean apart from constantly deramping it? I assumed you were a shorter? Best to move on old mate and forget any bad experiences from the past as it'll eat away at you! I'm a happy long term holder myself.

[lean5gb] 03/5/2023 23:19

I informed you previously, I haven't traded tlsa since it left britain. There's nothing to 'short' anyway. It's gonna flatline for the next 12 months, apart from the inevitable pump n dump. If it happens, trade it.

[jpuff] 03/5/2023 16:23

Maybe you should be shorting it then Lean along with Marcus if you're both so convinced it's got big loser written all over it?

[lean5gb] 02/5/2023 19:14

Yes.!..Rgt.... Adi... Okyo.... Accut.... Tils... 'Can kickers'? .Do your research..... See the story unfold.

[stenick] 02/5/2023 17:17

lean5gb23 Apr '23 - 18:05 - 17737 of 17756

Are you saying that just because GC bought an easy way to market that they are tarred with the same brush the history did.
Buy a secondhand car!!

[jpuff] 01/5/2023 10:45

With your expert and intimate knowledge of companies and the wider market Marcus, I'm surprised you're frequenting a lot of your time on obscure small company bulletin boards and not sunning yourself in faraway climes. If you're so good at predicting the future why not just retire and enjoy yourself instead? Enjoy your weekend too